Advertisement Natus prices public offer at $19.50 - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Natus prices public offer at $19.50

Natus Medical has announced the pricing of its public offering of four million shares of its common stock at $19.50 per share. All of the shares are being offered by Natus.

Natus has also granted the underwriters a 30-day option to purchase up to an additional 600,000 shares of its common stock to cover over-allotments, if any. The offering is expected to close on May 29, 2008, subject to the satisfaction of customary closing conditions.

Cowen and Company, and UBS Investment Bank are acting as joint bookrunning managers for the offering and Natixis Bleichroeder, Needham & Company, Raymond James & Associates, and Roth Capital Partners are acting as co-managers.